Three Biologic-Na&#xef;ve Patients with Allergic Bronchopulmonary Aspergillosis Showing Significant Clinical Improvement with Tezepelumab

RECOMMENDED

Tuberculosis

Clinically significant hemoptysis and all-cause mortality in patients with nontuberculous mycobacterial pulmonary disease

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Respir Med

Hyung K, Kim SA, Kwak N, Yim JJ, Kim JY

doi: 10.1016/j.rmed.2025.107946

ARDSCOPDEmphysema

Clinical and biologic profiles of patients with acute respiratory distress syndrome by prevalence of chronic obstructive pulmonary disease or emphysema; a cohort study

Respir Res

Nath S, Qurashi H, Kitsios GD, Bain W, Aneis H, Suber T, Prendergast N, Hensley M, Schaefer C, Zhang Y, Bon J, McVerry BJ, Evankovich J, Shah FA

doi: 10.1186/s12931-024-03027-2

RECOMMENDED

Sleep Apnea

Clinical significance of the hemoglobin-to-red blood cell distribution width ratio in patients with severe OSAS

★ 1 Recommended by Dr Martin Frey, Faculty Member

Sci Rep

Tan N, He Y, Li G, Liu P

doi: 10.1038/s41598-025-96693-1

Lung Cancer

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

J Clin Med

Ruznic E, Klebermass M, Zellinger B, Langer B, Grambozov B, Purevdorj A, Karner J, Gruber G, Stana M, Minasch D, Kirchhammer K, Steffal C, Stranzl H, Moosbrugger R, Feurstein P, Dieckmann K, Zehentmayr F, ALLSTAR Group

doi: 10.3390/jcm14030945

COMMENTED

Asthma

Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

J Asthma Allergy

Mobayed H, Al-Nesf M, Ibrahim T, Aqel S, Al-Ahmad M, Bousquet J

doi: 10.2147/JAA.S517784

Bronchi

Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Pollock J, Goeminne PC, Aliberti S, Polverino E, Crichton ML, Ringshausen FC, Dhar R, Vendrell M, Burgel PR, Haworth CS, De Soyza A, De Gracia J, Bossios A, Rademacher J, Grünewaldt A, McDonnell M, Stolz D, Sibila O, van der Eerden M, Kauppi P, Hill AT, Wilson R, Amorim A, Munteanu O, Menendez R, Torres A, Welte T, Blasi F, Boersma W, Elborn JS, Shteinberg M, Dimakou K, Chalmers JD, Loebinger MR, EMBARC registry investigators

doi: 10.1016/j.chest.2024.06.3843

RECOMMENDED

COPD

Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms

★ 1 Recommended by Dr Martin Frey, Faculty Member

Respir Med

Robles-Hernández RE, Montiel-Lopez F, Velázquez-Uncal M, Sansores RH, Hernández-Zenteno RJ, Pérez-Padilla R, Ramírez-Venegas A

doi: 10.1016/j.rmed.2025.108074

RECOMMENDED

Asthma

Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED

★ 1 Recommended by Dr Martin Frey, Faculty Member

Health Qual Life Outcomes

Meys R, Franssen FME, Van 't Hul AJ, Bakke PS, Caruso M, Dahlén B, Fowler SJ, Geiser T, Howarth PH, Horváth I, Krug N, Behndig AF, Singer F, Musial J, Shaw DE, Montuschi P, Zee AHM, Sterk PJ, Roberts G, Kermani NZ, Incalzi RA, Louis R, Andersson LI, Wagers SS, Dahlén SE, Chung KF, Adcock IM, Spruit MA, U-BIOPRED Study Group

doi: 10.1186/s12955-024-02321-3

COMMENTED

Pleural DiseasesPneumonia

The Impact of clinically significant pleural effusion on survival of US Veterans with cancer, congestive heart failure, and pneumonia: The Veterans Administration Lung Effusion Study (VALUES)

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

Chest

Chopra A, Hu K, Gemoets DE, Judson MA

doi: 10.1016/j.chest.2025.02.003

Pneumology

Three Biologic-Naïve Patients with Allergic Bronchopulmonary Aspergillosis Showing Significant Clinical Improvement with Tezepelumab

Related content

Clinically significant hemoptysis and all-cause mortality in patients with nontuberculous mycobacterial pulmonary disease

Clinical and biologic profiles of patients with acute respiratory distress syndrome by prevalence of chronic obstructive pulmonary disease or emphysema; a cohort study

Clinical significance of the hemoglobin-to-red blood cell distribution width ratio in patients with severe OSAS

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma

Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms

Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED

The Impact of clinically significant pleural effusion on survival of US Veterans with cancer, congestive heart failure, and pneumonia: The Veterans Administration Lung Effusion Study (VALUES)